Articles from Delphinus Medical Technologies

Austin Radiological Association is revolutionizing breast cancer screening for their patients with the use of FDA-approved SoftVue™ technology.

Delphinus Medical Technologies today announced that it has been awarded a national group purchasing agreement and Technology Breakthrough designation for its SoftVue™ Breast Ultrasound Tomography (UST) from Premier, inc. Delphinus is now listed as a top supplier for Premier’s members, who at their discretion, can take advantage of special pricing and terms pre-negotiated by Premier for SoftVue. SoftVue was also featured as one of the “latest and greatest” technologies at Premier’s annual conference, Breakthroughs 24.

Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Ultrasound Tomography (UST), today announced the latest installation of its breakthrough breast imaging technology at McLeod Regional Medical Center, Florence, S.C.

Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Ultrasound Tomography (UST), announced today the publication of a study comparing mammography in conjunction with SoftVue UST vs mammography alone in women with dense breasts. The study concluded that in women with dense breasts, mammography plus SoftVue UST improved cancer detection by radiologists versus mammography alone. The article “Comparison of Mammography and Mammography with Supplemental Whole-Breast US Tomography for Cancer Detection in Patients with Dense Breasts” has been published in the peer-reviewed journal, Radiology.

Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Tomographic Ultrasound, announced today that Michael Emery has joined the company as chief financial officer (CFO). Emery has over 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries.

Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Tomographic Ultrasound, announced today that Rama Gundlapalli has joined the company as Vice President of Engineering. Mr. Gundlapalli brings more than 30 years of experience in product development and engineering, having worked in startup, small and fortune 500 companies and applying knowledge in research and development to build out successful commercial product pipelines.

Delphinus Medical Technologies announced today the latest installation of its SoftVue™ 3D Whole Breast Ultrasound Tomography System since FDA approval of its advanced technology for screening women with dense breast tissue. UR Medicine is now the third medical center in the world offering dense breast cancer screening with SoftVue.